サマリー

医薬用グリセリンは、グリセロール、グリセリンとして知られる有機化合物で、主に製薬業界の賦形剤として使用されています。グリセリンは、医療用医薬品製剤において、滑らかさの向上、潤滑性、保湿性など、さまざまな効果を発揮する。最も一般的には、坐薬、咳止めシロップ、エリキシル剤、去痰剤などの製剤に利用されています。
個々の処方品としては、グリセリンは高浸透圧剤、浸透圧利尿剤、眼科用剤として使用されてきました。緑内障の治療では眼圧を下げるために点眼薬として、便秘の短期治療では溶液または座薬として、大腸内視鏡検査の前には腸を排出するために、また一部の眼科手術では使用されることがある。また、脳内圧を下げるために静脈内投与されたり、保湿剤として皮膚に外用されることもあります。グリセリンは、農業、食品、製薬産業において、他にも多くの用途があります。
医薬品用グリセリン製品の採用が増加しているのは、さまざまな製品にグリセリンが使用されるようになったためです。グリセリンは医薬品の賦形剤として使用されるため、世界的にこれらの製品の需要が医薬品グリセリンベース製品市場を牽引すると予想されます。
さらに、ハーブや植物チンキの調合におけるアルコールの代替品としてグリセリンの使用が増加していることも、市場を牽引すると予想されます。さらに、その低コストと、皮膚の火傷や軽度の皮膚刺激における保湿剤などの様々な医療給付のために、製薬業界におけるグリセリンの採用の増加は、今後1年間の市場の成長を促進する主要因である.
医薬品グリセリン製品市場は、薬剤の種類と地域に基づいて区分されています。薬剤の種類に基づいて、市場は皮膚科、眼科、咳止めグリセリン直腸、狭心症に分けられています。地域別では、医薬品グリセリンベースの製品市場は、北米、欧州、アジア太平洋、LAMEAに分かれています。
世界の医薬品グリセリンベース製品市場で事業を展開している主要企業は、ジョンソン・エンド・ジョンソン、アボット、AbbVie Inc.、Bausch Health Companies Inc.Bausch Health Companies Inc.、武田薬品工業、The Dow Chemical Company、Dupont、Emery Oleochemicals、Croda International Plc、Lonzaが含まれます。

ページTOPに戻る

目次

CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET, BY DRUG TYPE
4.1 Overview
4.1.1 Market size and forecast
4.2 Dermatological
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Opthalmic
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.4 Cough Remidies
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market analysis by country
4.5 Glycerine Rectal
4.5.1 Key market trends, growth factors and opportunities
4.5.2 Market size and forecast, by region
4.5.3 Market analysis by country
4.6 Angina
4.6.1 Key market trends, growth factors and opportunities
4.6.2 Market size and forecast, by region
4.6.3 Market analysis by country
CHAPTER 5: PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET, BY REGION
5.1 Overview
5.1.1 Market size and forecast
5.2 North America
5.2.1 Key trends and opportunities
5.2.2 North America Market size and forecast, by Drug Type
5.2.3 North America Market size and forecast, by country
5.2.3.1 U.S.
5.2.3.1.1 Market size and forecast, by Drug Type
5.2.3.2 Canada
5.2.3.2.1 Market size and forecast, by Drug Type
5.2.3.3 Mexico
5.2.3.3.1 Market size and forecast, by Drug Type
5.3 Europe
5.3.1 Key trends and opportunities
5.3.2 Europe Market size and forecast, by Drug Type
5.3.3 Europe Market size and forecast, by country
5.3.3.1 Germany
5.3.3.1.1 Market size and forecast, by Drug Type
5.3.3.2 France
5.3.3.2.1 Market size and forecast, by Drug Type
5.3.3.3 U.K.
5.3.3.3.1 Market size and forecast, by Drug Type
5.3.3.4 Italy
5.3.3.4.1 Market size and forecast, by Drug Type
5.3.3.5 Spain
5.3.3.5.1 Market size and forecast, by Drug Type
5.3.3.6 Rest of Europe
5.3.3.6.1 Market size and forecast, by Drug Type
5.4 Asia-Pacific
5.4.1 Key trends and opportunities
5.4.2 Asia-Pacific Market size and forecast, by Drug Type
5.4.3 Asia-Pacific Market size and forecast, by country
5.4.3.1 Japan
5.4.3.1.1 Market size and forecast, by Drug Type
5.4.3.2 China
5.4.3.2.1 Market size and forecast, by Drug Type
5.4.3.3 Australia
5.4.3.3.1 Market size and forecast, by Drug Type
5.4.3.4 India
5.4.3.4.1 Market size and forecast, by Drug Type
5.4.3.5 South Korea
5.4.3.5.1 Market size and forecast, by Drug Type
5.4.3.6 Rest Of Asia Pacific
5.4.3.6.1 Market size and forecast, by Drug Type
5.5 LAMEA
5.5.1 Key trends and opportunities
5.5.2 LAMEA Market size and forecast, by Drug Type
5.5.3 LAMEA Market size and forecast, by country
5.5.3.1 Brazil
5.5.3.1.1 Market size and forecast, by Drug Type
5.5.3.2 South Africa,
5.5.3.2.1 Market size and forecast, by Drug Type
5.5.3.3 Saudi Arabia
5.5.3.3.1 Market size and forecast, by Drug Type
5.5.3.4 Rest of LAMEA
5.5.3.4.1 Market size and forecast, by Drug Type
CHAPTER 6: COMPANY LANDSCAPE
6.1. Introduction
6.2. Top winning strategies
6.3. Product Mapping of Top 10 Player
6.4. Competitive Dashboard
6.5. Competitive Heatmap
6.6. Key developments
CHAPTER 7: COMPANY PROFILES
7.1 Johnson and Johnson
7.1.1 Company overview
7.1.2 Company snapshot
7.1.3 Operating business segments
7.1.4 Product portfolio
7.1.5 Business performance
7.1.6 Key strategic moves and developments
7.2 Abbott Laboratories
7.2.1 Company overview
7.2.2 Company snapshot
7.2.3 Operating business segments
7.2.4 Product portfolio
7.2.5 Business performance
7.2.6 Key strategic moves and developments
7.3 AbbVie Inc
7.3.1 Company overview
7.3.2 Company snapshot
7.3.3 Operating business segments
7.3.4 Product portfolio
7.3.5 Business performance
7.3.6 Key strategic moves and developments
7.4 Bausch Health Companies Inc.
7.4.1 Company overview
7.4.2 Company snapshot
7.4.3 Operating business segments
7.4.4 Product portfolio
7.4.5 Business performance
7.4.6 Key strategic moves and developments
7.5 Takeda Pharmaceutical Company
7.5.1 Company overview
7.5.2 Company snapshot
7.5.3 Operating business segments
7.5.4 Product portfolio
7.5.5 Business performance
7.5.6 Key strategic moves and developments
7.6 Takeda Pharmaceutical Company Ltd
7.6.1 Company overview
7.6.2 Company snapshot
7.6.3 Operating business segments
7.6.4 Product portfolio
7.6.5 Business performance
7.6.6 Key strategic moves and developments
7.7 The Dow Chemical Company
7.7.1 Company overview
7.7.2 Company snapshot
7.7.3 Operating business segments
7.7.4 Product portfolio
7.7.5 Business performance
7.7.6 Key strategic moves and developments
7.8 dupoint
7.8.1 Company overview
7.8.2 Company snapshot
7.8.3 Operating business segments
7.8.4 Product portfolio
7.8.5 Business performance
7.8.6 Key strategic moves and developments
7.9 Emery Oleochemicals
7.9.1 Company overview
7.9.2 Company snapshot
7.9.3 Operating business segments
7.9.4 Product portfolio
7.9.5 Business performance
7.9.6 Key strategic moves and developments
7.10 Croda International plc
7.10.1 Company overview
7.10.2 Company snapshot
7.10.3 Operating business segments
7.10.4 Product portfolio
7.10.5 Business performance
7.10.6 Key strategic moves and developments
7.11 Capsugel
7.11.1 Company overview
7.11.2 Company snapshot
7.11.3 Operating business segments
7.11.4 Product portfolio
7.11.5 Business performance
7.11.6 Key strategic moves and developments


LIST OF TABLES
TABLE 1. GLOBAL PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET, BY DRUG TYPE, 2020-2030,($MILLION)
TABLE 2. PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET REVENUE, FOR DERMATOLOGICAL, BY REGION , 2020-2030,($MILLION)
TABLE 3. PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET DERMATOLOGICAL BY COUNTRY, 2020-2030,($MILLION)
TABLE 4. PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET REVENUE, FOR OPTHALMIC, BY REGION , 2020-2030,($MILLION)
TABLE 5. PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET OPTHALMIC BY COUNTRY, 2020-2030,($MILLION)
TABLE 6. PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET REVENUE, FOR COUGH REMIDIES, BY REGION , 2020-2030,($MILLION)
TABLE 7. PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET COUGH REMIDIES BY COUNTRY, 2020-2030,($MILLION)
TABLE 8. PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET REVENUE, FOR GLYCERINE RECTAL, BY REGION , 2020-2030,($MILLION)
TABLE 9. PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET GLYCERINE RECTAL BY COUNTRY, 2020-2030,($MILLION)
TABLE 10. PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET REVENUE, FOR ANGINA, BY REGION , 2020-2030,($MILLION)
TABLE 11. PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET ANGINA BY COUNTRY, 2020-2030,($MILLION)
TABLE 12. PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET, BY REGION, 2020-2030,($MILLION)
TABLE 13. NORTH AMERICA PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET, BY DRUG TYPE, 2020-2030,($MILLION)
TABLE 14. NORTH AMERICA PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 15. U.S. PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET BY DRUG TYPE 2020-2030,($MILLION)
TABLE 16. CANADA PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET BY DRUG TYPE 2020-2030,($MILLION)
TABLE 17. MEXICO PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET BY DRUG TYPE 2020-2030,($MILLION)
TABLE 18. EUROPE PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET, BY DRUG TYPE, 2020-2030,($MILLION)
TABLE 19. EUROPE PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 20. GERMANY PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET BY DRUG TYPE 2020-2030,($MILLION)
TABLE 21. FRANCE PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET BY DRUG TYPE 2020-2030,($MILLION)
TABLE 22. U.K. PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET BY DRUG TYPE 2020-2030,($MILLION)
TABLE 23. ITALY PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET BY DRUG TYPE 2020-2030,($MILLION)
TABLE 24. SPAIN PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET BY DRUG TYPE 2020-2030,($MILLION)
TABLE 25. REST OF EUROPE PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET BY DRUG TYPE 2020-2030,($MILLION)
TABLE 26. ASIA-PACIFIC PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET, BY DRUG TYPE, 2020-2030,($MILLION)
TABLE 27. ASIA-PACIFIC PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 28. JAPAN PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET BY DRUG TYPE 2020-2030,($MILLION)
TABLE 29. CHINA PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET BY DRUG TYPE 2020-2030,($MILLION)
TABLE 30. AUSTRALIA PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET BY DRUG TYPE 2020-2030,($MILLION)
TABLE 31. INDIA PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET BY DRUG TYPE 2020-2030,($MILLION)
TABLE 32. SOUTH KOREA PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET BY DRUG TYPE 2020-2030,($MILLION)
TABLE 33. REST OF ASIA PACIFIC PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET BY DRUG TYPE 2020-2030,($MILLION)
TABLE 34. LAMEA PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET, BY DRUG TYPE, 2020-2030,($MILLION)
TABLE 35. LAMEA PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 36. BRAZIL PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET BY DRUG TYPE 2020-2030,($MILLION)
TABLE 37. SOUTH AFRICA, PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET BY DRUG TYPE 2020-2030,($MILLION)
TABLE 38. SAUDI ARABIA PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET BY DRUG TYPE 2020-2030,($MILLION)
TABLE 39. REST OF LAMEA PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET BY DRUG TYPE 2020-2030,($MILLION)
TABLE 40.JOHNSON AND JOHNSON: COMPANY SNAPSHOT
TABLE 41.JOHNSON AND JOHNSON: OPERATING SEGMENTS
TABLE 42.JOHNSON AND JOHNSON: PRODUCT PORTFOLIO
TABLE 43.JOHNSON AND JOHNSON: NET SALES,
TABLE 44.JOHNSON AND JOHNSON: KEY STRATERGIES
TABLE 45.ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 46.ABBOTT LABORATORIES: OPERATING SEGMENTS
TABLE 47.ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 48.ABBOTT LABORATORIES: NET SALES,
TABLE 49.ABBOTT LABORATORIES: KEY STRATERGIES
TABLE 50.ABBVIE INC: COMPANY SNAPSHOT
TABLE 51.ABBVIE INC: OPERATING SEGMENTS
TABLE 52.ABBVIE INC: PRODUCT PORTFOLIO
TABLE 53.ABBVIE INC: NET SALES,
TABLE 54.ABBVIE INC: KEY STRATERGIES
TABLE 55.BAUSCH HEALTH COMPANIES INC.: COMPANY SNAPSHOT
TABLE 56.BAUSCH HEALTH COMPANIES INC.: OPERATING SEGMENTS
TABLE 57.BAUSCH HEALTH COMPANIES INC.: PRODUCT PORTFOLIO
TABLE 58.BAUSCH HEALTH COMPANIES INC.: NET SALES,
TABLE 59.BAUSCH HEALTH COMPANIES INC.: KEY STRATERGIES
TABLE 60.TAKEDA PHARMACEUTICAL COMPANY: COMPANY SNAPSHOT
TABLE 61.TAKEDA PHARMACEUTICAL COMPANY: OPERATING SEGMENTS
TABLE 62.TAKEDA PHARMACEUTICAL COMPANY: PRODUCT PORTFOLIO
TABLE 63.TAKEDA PHARMACEUTICAL COMPANY: NET SALES,
TABLE 64.TAKEDA PHARMACEUTICAL COMPANY: KEY STRATERGIES
TABLE 65.TAKEDA PHARMACEUTICAL COMPANY LTD: COMPANY SNAPSHOT
TABLE 66.TAKEDA PHARMACEUTICAL COMPANY LTD: OPERATING SEGMENTS
TABLE 67.TAKEDA PHARMACEUTICAL COMPANY LTD: PRODUCT PORTFOLIO
TABLE 68.TAKEDA PHARMACEUTICAL COMPANY LTD: NET SALES,
TABLE 69.TAKEDA PHARMACEUTICAL COMPANY LTD: KEY STRATERGIES
TABLE 70.THE DOW CHEMICAL COMPANY: COMPANY SNAPSHOT
TABLE 71.THE DOW CHEMICAL COMPANY: OPERATING SEGMENTS
TABLE 72.THE DOW CHEMICAL COMPANY: PRODUCT PORTFOLIO
TABLE 73.THE DOW CHEMICAL COMPANY: NET SALES,
TABLE 74.THE DOW CHEMICAL COMPANY: KEY STRATERGIES
TABLE 75.DUPOINT: COMPANY SNAPSHOT
TABLE 76.DUPOINT: OPERATING SEGMENTS
TABLE 77.DUPOINT: PRODUCT PORTFOLIO
TABLE 78.DUPOINT: NET SALES,
TABLE 79.DUPOINT: KEY STRATERGIES
TABLE 80.EMERY OLEOCHEMICALS: COMPANY SNAPSHOT
TABLE 81.EMERY OLEOCHEMICALS: OPERATING SEGMENTS
TABLE 82.EMERY OLEOCHEMICALS: PRODUCT PORTFOLIO
TABLE 83.EMERY OLEOCHEMICALS: NET SALES,
TABLE 84.EMERY OLEOCHEMICALS: KEY STRATERGIES
TABLE 85.CRODA INTERNATIONAL PLC: COMPANY SNAPSHOT
TABLE 86.CRODA INTERNATIONAL PLC: OPERATING SEGMENTS
TABLE 87.CRODA INTERNATIONAL PLC: PRODUCT PORTFOLIO
TABLE 88.CRODA INTERNATIONAL PLC: NET SALES,
TABLE 89.CRODA INTERNATIONAL PLC: KEY STRATERGIES
TABLE 90.CAPSUGEL: COMPANY SNAPSHOT
TABLE 91.CAPSUGEL: OPERATING SEGMENTS
TABLE 92.CAPSUGEL: PRODUCT PORTFOLIO
TABLE 93.CAPSUGEL: NET SALES,
TABLE 94.CAPSUGEL: KEY STRATERGIES


LIST OF FIGURES
FIGURE 1.PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET SEGMENTATION
FIGURE 2.PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET,2020-2030
FIGURE 3.PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET,2020-2030
FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
FIGURE 5.PORTER FIVE-1
FIGURE 6.PORTER FIVE-2
FIGURE 7.PORTER FIVE-3
FIGURE 8.PORTER FIVE-4
FIGURE 9.PORTER FIVE-5
FIGURE 10.TOP PLAYER POSITIONING
FIGURE 11.PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
FIGURE 11.PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET,BY DRUG TYPE,2020(%)
FIGURE 12.COMPARATIVE SHARE ANALYSIS OF DERMATOLOGICAL PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET,2020-2030(%)
FIGURE 13.COMPARATIVE SHARE ANALYSIS OF OPTHALMIC PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET,2020-2030(%)
FIGURE 14.COMPARATIVE SHARE ANALYSIS OF COUGH REMIDIES PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET,2020-2030(%)
FIGURE 15.COMPARATIVE SHARE ANALYSIS OF GLYCERINE RECTAL PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET,2020-2030(%)
FIGURE 16.COMPARATIVE SHARE ANALYSIS OF ANGINA PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET,2020-2030(%)
FIGURE 17.PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET BY REGION,2020
FIGURE 18.U.S. PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET,2020-2030($MILLION)
FIGURE 19.CANADA PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET,2020-2030($MILLION)
FIGURE 20.MEXICO PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET,2020-2030($MILLION)
FIGURE 21.GERMANY PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET,2020-2030($MILLION)
FIGURE 22.FRANCE PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET,2020-2030($MILLION)
FIGURE 23.U.K. PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET,2020-2030($MILLION)
FIGURE 24.ITALY PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET,2020-2030($MILLION)
FIGURE 25.SPAIN PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET,2020-2030($MILLION)
FIGURE 26.REST OF EUROPE PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET,2020-2030($MILLION)
FIGURE 27.JAPAN PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET,2020-2030($MILLION)
FIGURE 28.CHINA PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET,2020-2030($MILLION)
FIGURE 29.AUSTRALIA PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET,2020-2030($MILLION)
FIGURE 30.INDIA PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET,2020-2030($MILLION)
FIGURE 31.SOUTH KOREA PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET,2020-2030($MILLION)
FIGURE 32.REST OF ASIA PACIFIC PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET,2020-2030($MILLION)
FIGURE 33.BRAZIL PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET,2020-2030($MILLION)
FIGURE 34.SOUTH AFRICA, PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET,2020-2030($MILLION)
FIGURE 35.SAUDI ARABIA PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET,2020-2030($MILLION)
FIGURE 36.REST OF LAMEA PHARMACEUTICAL GLYCERIN BASED PRODUCTS MARKET,2020-2030($MILLION)
FIGURE 37. TOP WINNING STRATEGIES, BY YEAR
FIGURE 38. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 39. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 40.PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 41.COMPETITIVE DASHBOARD
FIGURE 42.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
FIGURE 43.JOHNSON AND JOHNSON.: NET SALES ,($MILLION)
FIGURE 44.ABBOTT LABORATORIES.: NET SALES ,($MILLION)
FIGURE 45.ABBVIE INC.: NET SALES ,($MILLION)
FIGURE 46.BAUSCH HEALTH COMPANIES INC..: NET SALES ,($MILLION)
FIGURE 47.TAKEDA PHARMACEUTICAL COMPANY.: NET SALES ,($MILLION)
FIGURE 48.TAKEDA PHARMACEUTICAL COMPANY LTD.: NET SALES ,($MILLION)
FIGURE 49.THE DOW CHEMICAL COMPANY.: NET SALES ,($MILLION)
FIGURE 50.DUPOINT.: NET SALES ,($MILLION)
FIGURE 51.EMERY OLEOCHEMICALS.: NET SALES ,($MILLION)
FIGURE 52.CRODA INTERNATIONAL PLC.: NET SALES ,($MILLION)
FIGURE 53.CAPSUGEL.: NET SALES ,($MILLION)